CRN unveils WellComms 2025 agenda
The event will include sessions on brand protection, influencer partnerships, effective press outreach, and more.
Thorvardur de Shong
Ulta and Target to end in-store beauty partnership in 2026
Launched in August 2021, the collaboration brought prestige beauty brands to select Target stores and Target.com.
Costco pharmacies to stop offering abortion pill
The decision has drawn praise from religious investors and criticism from abortion rights supporters, as the battle over the pill shifts to CVS and Walgreens.
Aurobindo Pharma to acquire Lannett for $250M
The transaction is subject to regulatory approvals, including clearance from the U.S. Federal Trade Commission, and is expected to close within 8 to 12 months.
Cool Sips x poppi debut limited-edition dirty sodas
The partnership marks Cool Sips’ first collaboration with a national brand since launching in 2024, underscoring its rapid growth in the competitive beverage market.
Resonate: Most consumers only feeling mild tariff impact — For now
“Americans aren't pulling back yet, but tariffs have the potential to cause consumer behaviors to shift overnight,” said Bryan Gernert, CEO of Resonate.
Swiss government to meet pharma firms over U.S. tariffs
Pharma is Switzerland’s largest export sector to the U.S., accounting for half of all Swiss shipments to the States.
Remote patient monitoring market to top $40B by 2032
Home healthcare settings are projected to account for nearly one-third of RPM device demand in 2025.
WCC Biomedical brings WINMAP microneedle innovation to NACDS TSE
WCC sees potential for WINMAP to improve health equity, especially in low-resource areas where injection-based therapies are difficult to administer.
Kenvue cuts 2025 outlook as analysts lower price targets
“Kenvue is clearly a ‘show me’ story” that must prove it can deliver steady improvement before the stock can regain momentum.”
Pharmacy groups urge court to uphold Tennessee's PBM reform law
National and state pharmacy groups emphasize the need for state control to regulate PBMs and protect local pharmacies, patients, and health plans.
CVS Health joins “MAHA” effort with $20B commitment
“How the private sector and government collaborate on this will be vital to creating a health care system that’s truly built to serve patients.“
Trump says pharma tariffs will begin soon, could reach 250%
“We want pharmaceuticals made in our country,” Trump said.
Roche gets FDA approval for all‑in‑one respiratory virus test
Roche says the launch will help labs and clinics prepare for a busy respiratory virus season, when COVID-19, flu, and RSV often spread simultaneously.
NRF warns new tariffs will push prices higher, threaten jobs
NRF Executive Vice President of Government Relations David French urged the administration to pursue “binding trade agreements that truly open markets by lowering tariffs, not raising them.”
Health care rare bright spot in weakening job market
While most industries struggle, health care continues to hire, but tariffs could test its resilience.